Aclaris Therapeutics ACRS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's operating margin?
- Aclaris Therapeutics (ACRS) reported operating margin of -961.9% in Q1 2026.
- How has Aclaris Therapeutics's operating margin changed year-over-year?
- Aclaris Therapeutics's operating margin decreased by 21.2% year-over-year, from -793.6% to -961.9%.
- What is the long-term trend for Aclaris Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's operating margin has grown at a 4.4% compound annual growth rate (CAGR), from -785.4% to -975.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.